Dis Colon Rectum24 Nov 2023
Japanese colorectal cancer patients (stages I-III) witnessed promising employment outcomes within 12 months post-surgery, with a 79% return-to-work rate. The study identified risks for delayed return, including advanced tumor stage, stoma presence, severe complications, shorter work tenure, and lower return-to-work inclination. Factors contributing to unemployment…
Am J Surg24 Nov 2023
In the quest for superior hernia care, researchers explored designated hernia centers (DHCs). Analyzing over 14,000 ventral hernia repairs (VHRs) from 261 sites, they found no clear advantage to DHCs. Surprisingly, non-designated hernia centers (NDHCs) displayed fewer 30-day complications and lower one-year hernia recurrence rates.…
Langenbecks Arch Surg24 Nov 2023
Inguinal hernia patients with pre-op pain face potential irreversible nerve damage, signaling a road to chronic post-op pain (CPIP). Studying 40 patients who underwent hernia repair, researchers found intraneural fibrosis within the ilioinguinal nerve in all pre-op pain cases. The fibrosis degree correlated positively with…
BJS Open24 Nov 2023
In the world of adrenal gland dilemmas, researchers delve into the showdown between total adrenalectomy and its hip sibling, subtotal adrenalectomy, for bilateral pheochromocytoma. Analyzing 10 studies with 1202 patients, they uncover that subtotal adrenalectomy, while saving from adrenal insufficiency, packs a punch with a…
Ann Surg Oncol23 Nov 2023
In the exploration of treatments for advanced esophageal squamous cell carcinoma (ESCC), researchers compared outcomes of neoadjuvant chemotherapy (NCT), neoadjuvant chemoradiotherapy (NCRT), and neoadjuvant immunochemotherapy (NICT). NCRT and NICT groups exhibited superior pathological responses, with higher pathologic complete response rates (29.9% and 23.6%, respectively) compared…
Ann Surg Oncol23 Nov 2023
In a phase II study, researchers explored the efficacy of intraperitoneal paclitaxel combined with S-1 and cisplatin for gastric cancer with peritoneal metastasis. Among 53 patients, the treatment achieved a 73.6% 1-year overall survival rate, meeting the primary endpoint. The median survival time was 19.4…
BMC Surg23 Nov 2023
In a comprehensive study of 3,684 patients undergoing percutaneous transesophageal gastro-tubing (PTEG) in Japan, researchers found a mere 1.3% complication rate. PTEG served diverse purposes, with 1,455 cases for decompression and 2,193 for feeding. Notably, complications led to minimal invasive treatments, predominantly red blood cell…
Surg Endosc23 Nov 2023
In the robotic frontier of pancreaticoduodenectomy, a study of 400 patients revealed a 10.5% unplanned conversion rate. Men, especially, faced this detour, often due to vascular surprises or bleeding challenges. While conversions meant shorter surgeries, they spiked blood loss and complications, with higher mortality rates.…
Surg Endosc23 Nov 2023
In a game-changing move for superficial colorectal cancer, researchers crafted a user-friendly nomogram for personalized lymph node metastasis (LNM) prediction after endoscopic surgery. Analyzing 608 cases, the nomogram trumped traditional CT scans, showcasing superior predictive power, as validated by ROC, DCA, and clinical impact curves.…
Surg Endosc23 Nov 2023
Exploring the surge in indocyanine green's (ICG) role in surgeries, this meta-review of 116 studies uncovered varying ICG applications, from bariatric to urologic procedures. Despite benefits in anastomotic leak prevention, especially in colorectal surgery, and limited advantages in sentinel node detection, the study cautions on…